Induced pluripotent stem cells: A novel frontier in the study of human primary immunodeficiencies  Itai M. Pessach, MD, PhD, Jose Ordovas-Montanes, BA,

Slides:



Advertisements
Similar presentations
Cell Therapy in CV Disease: Newest Evidence. 2 Induction of pluripotent stem cells from human fibroblasts Study Source of fibroblasts Transcription factors.
Advertisements

Induced pluripotent stem cells: A novel frontier in the study of human primary immunodeficiencies Itai M. Pessach, MD, PhD, Jose Ordovas-Montanes, BA,
Volume 64, Issue 5, Pages (November 2013)
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Olga Genbacev, Ph. D. , Ana Krtolica, Ph. D. , Tamara Zdravkovic, M. S
Volume 17, Issue 2, Pages (August 2015)
Volume 8, Issue 4, Pages (April 2017)
Volume 15, Issue 6, Pages (June 2007)
Volume 16, Issue 3, Pages (March 2008)
Volume 13, Issue 2, Pages (August 2013)
Generation of Induced Pluripotent Stem Cell Lines from Adult Rat Cells
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors  Kazutoshi Takahashi, Shinya Yamanaka  Cell 
Volume 64, Issue 5, Pages (November 2013)
Volume 9, Issue 5, Pages (November 2017)
Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells  Youwen Yang, PhD, Hans Michael Haitchi, MD,
Volume 4, Issue 6, Pages (June 2009)
Generation of iPSCs from cultured human malignant cells
Disease-Specific Induced Pluripotent Stem Cells
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Requirement of leukemia inhibitory factor for establishing and maintaining embryonic stem cells in mice  Jae Hee Lee, B.Sc., Eun Ju Lee, Ph.D., Chae Hyun.
The proteome of Toll-like receptor 3–stimulated human immortalized fibroblasts: Implications for susceptibility to herpes simplex virus encephalitis 
Molecular Therapy - Nucleic Acids
Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cells  Michaela Kunova, Kamil Matulka, Livia Eiselleova,
Volume 5, Issue 4, Pages (October 2015)
Patient-Specific Naturally Gene-Reverted Induced Pluripotent Stem Cells in Recessive Dystrophic Epidermolysis Bullosa  Jakub Tolar, John A. McGrath, Lily.
Advances in basic and clinical immunology in 2011
Reprogramming of T Cells from Human Peripheral Blood
Meeyoung Cho, Ph. D. , Eun Ju Lee, Ph. D. , Hyun Nam, Ph. D
Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency  Kerstin Felgentreff, MD,
Olga Genbacev, Ph. D. , Ana Krtolica, Ph. D. , Tamara Zdravkovic, M. S
Volume 5, Issue 3, Pages (September 2015)
Volume 4, Issue 2, Pages (February 2015)
Transduction of Human Embryonic Stem Cells by Foamy Virus Vectors
Donald B. Kohn, MD, Caroline Y. Kuo, MD 
NEMO is a key component of NF-κB– and IRF-3–dependent TLR3-mediated immunity to herpes simplex virus  Magali Audry, PhD, Michael Ciancanelli, PhD, Kun.
Claire A. Higgins, Munenari Itoh, Keita Inoue, Gavin D
Volume 13, Issue 1, Pages (July 2013)
Volume 13, Issue 2, Pages (August 2013)
Itai M. Pessach, MD, PhD, Luigi D. Notarangelo, MD 
Volume 2, Issue 6, Pages (June 2014)
Volume 17, Issue 2, Pages (August 2015)
Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
Induced pluripotent stem cells: A new era for hepatology
Volume 7, Issue 1, Pages (July 2010)
Generation of neural cells using iPSCs from sleep bruxism patients with 5-HT2A polymorphism  Yurie Hoashi, D.D.S., Ph.D., Satoshi Okamoto, Ph.D., Yuka.
Volume 10, Issue 6, Pages (June 2018)
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations  Giovanna.
A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization.
Andriana G Kotini, Michel Sadelain, Eirini P Papapetrou 
Disease-Specific Induced Pluripotent Stem Cells
Volume 6, Issue 2, Pages (February 2016)
Volume 7, Issue 4, Pages (October 2016)
Volume 9, Issue 5, Pages (November 2017)
Volume 16, Issue 9, Pages (August 2016)
Volume 131, Issue 5, Pages (November 2007)
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Volume 6, Issue 6, Pages (June 2016)
Volume 3, Issue 6, Pages (December 2008)
Volume 13, Issue 3, Pages (September 2013)
Volume 7, Issue 1, Pages (July 2010)
Volume 3, Issue 3, Pages (September 2008)
Jakub Tolar, Lily Xia, Megan J. Riddle, Chris J. Lees, Cindy R
Multiple Epigenetic Modifiers Induce Aggressive Viral Extinction in Extraembryonic Endoderm Stem Cells  Michael C. Golding, Liyue Zhang, Mellissa R.W.
Volume 11, Issue 6, Pages (June 2005)
Volume 9, Issue 5, Pages (November 2017)
Embryonic and adult stem cell therapy
Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells  Hong Ji, PhD, Xue Zhang,
Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature  Can N. Kocabas, MD, Akif.
Novel presentation of Omenn syndrome in association with aniridia
First reported case of Omenn syndrome in a patient with reticular dysgenesis  Lauren A. Henderson, MD, Francesco Frugoni, PhD, Gregory Hopkins, BS, Waleed.
Presentation transcript:

Induced pluripotent stem cells: A novel frontier in the study of human primary immunodeficiencies  Itai M. Pessach, MD, PhD, Jose Ordovas-Montanes, BA, Shen-Ying Zhang, MD, Jean-Laurent Casanova, MD, PhD, Silvia Giliani, PhD, Andrew R. Gennery, MD, Waleed Al-Herz, MD, Philip D. Manos, PhD, Thorsten M. Schlaeger, PhD, In-Hyun Park, PhD, Francesca Rucci, PhD, Suneet Agarwal, MD, PhD, Gustavo Mostoslavsky, MD, PhD, George Q. Daley, MD, Luigi D. Notarangelo, MD  Journal of Allergy and Clinical Immunology  Volume 127, Issue 6, Pages 1400-1407.e4 (June 2011) DOI: 10.1016/j.jaci.2010.11.008 Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 PID-specific iPSCs express markers of pluripotency. PID-specific iPSCs have morphology similar to that seen in hES cells (left column) when grown in coculture with iMEFs and express pluripotency markers, including Tra-1–81, OCT4, SSEA4, SSEA3, NANOG, and Tra-1-60, as demonstrated by means of immunohistochemistry. Nuclear staining with Hoechst 33342 is shown in the second and sixth columns to indicate the total cell content per image. CHH, Cartilage hair hypoplasia; HSE, herpes simplex encephalitis; OS, Omenn syndrome; SCID, severe combined immune deficiency. Journal of Allergy and Clinical Immunology 2011 127, 1400-1407.e4DOI: (10.1016/j.jaci.2010.11.008) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 PID-specific iPSCs show a gene expression panel similar to that of reference iPSCs derived from a healthy control subject. Quantitative real-time PCR (QRT-PCR) assay for gene expression of OCT4, KLF4, MYC, SOX2, NANOG, REX1, GDF3, and hTERT was performed in iPSCs derived from healthy control subjects and from patients with PID and compared with the pattern observed in a previously established control human iPSC line obtained by reprogramming with 4 different retroviral vectors.17 QRT-PCR reactions were normalized against β-actin (ACTB). Expression was calculated by using the ddCt method relative to expression levels in the individual parental fibroblast cell lines for the normal and PID-specific iPSC or normal control human fibroblasts for the human embryonic stem cells. CHH, Cartilage hair hypoplasia; HSE, herpes simplex encephalitis; OS, Omenn syndrome; SCID, severe combined immune deficiency. Journal of Allergy and Clinical Immunology 2011 127, 1400-1407.e4DOI: (10.1016/j.jaci.2010.11.008) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Differentiation of PID-specific iPSCs reveals lineage-specific gene expression. PID-specific iPSC were allowed to differentiate into embryoid bodies by means of culture in a bFGF-free hES medium and without coculture with feeder cells. Robust formation of tight and well-formed cell clusters was detected by day 7 and became cystic by day 10 (upper row in each cell-specific panel). Quantitative real-time polymerase chain reaction (QRT-PCR) gene expression analysis of the derived embryoid bodies after 10 days shows increased expression of lineage-specific markers from each of the 3 embryonic germ layers, including AFP and GATA4 (endoderm), RUNX1 and Brachyury (mesoderm), and NCAM and NESTIN (ectoderm). QRT-PCR reactions were normalized against β-actin (ACTB). Expression was calculated by using the ddCT method relative to expression levels in undifferentiated iPSCs. Black and white bars identify undifferentiated iPSCs and day 10 embryoid bodies, respectively. CHH, Cartilage hair hypoplasia; HSE, herpes simplex encephalitis; OS, Omenn syndrome; SCID, severe combined immune deficiency. Journal of Allergy and Clinical Immunology 2011 127, 1400-1407.e4DOI: (10.1016/j.jaci.2010.11.008) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Patient’s origin and chromosomal integrity of the PID-specific iPSCs. A, PCR amplification followed by DNA sequencing of genomic DNA derived from the PID-specific iPSCs and their parental fibroblasts was performed by using specific primers corresponding to the disease-causing mutations for each of the lines and demonstrated that the PID-specific iPSC lines carry the same disease-causing mutations as their parental fibroblasts. In the case of the first allele (c.256-257del) of the RAG1-mutated patient with Omenn syndrome, genetic identity between patient-derived iPSCs and fibroblasts was demonstrated on cloning and sequencing of the specific product. B, PID-specific iPSCs were analyzed for chromosomal integrity by using G-banding karyotyping. CHH, Cartilage hair hypoplasia; HSE, herpes simplex encephalitis; OS, Omenn syndrome; SCID, severe combined immune deficiency. Journal of Allergy and Clinical Immunology 2011 127, 1400-1407.e4DOI: (10.1016/j.jaci.2010.11.008) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Schematic representation of the process of producing PID-specific iPSCs and their possible use in disease characterization and gene correction. CNS, Central nervous system; GI, gastrointestinal; HSC, hematopoietic stem cell; LTR, long terminal repeat. Journal of Allergy and Clinical Immunology 2011 127, 1400-1407.e4DOI: (10.1016/j.jaci.2010.11.008) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Somatic cell reprogramming to pluripotency using the STEMCCA lentiviral vector. Schematic representation of STEMCCA lentiviral vector coding for the expression of a “stem cell cassette” composed of a single polycistronic mRNA containing an internal ribosome entry site (IRES) element separating 2 fusion cistrons. The first cistron consists of OCT4 fused to KLF4 coding sequences through the use of intervening sequences encoding “self-cleaving” 2A peptides. The second cistron consists of the coding sequences of SOX2 and cMYC fused in a similar manner. The polycistronic transcript is driven by a constitutive elongation factor-1α (EF1a) promoter and is flanked by LoxP sites enabling future Cre-mediated excision, as previously described.E1-E4 LTR, Long terminal repeat; PSI-RRE-cpPu, packaging signal-rev response element-central polypurine track; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element. Journal of Allergy and Clinical Immunology 2011 127, 1400-1407.e4DOI: (10.1016/j.jaci.2010.11.008) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions